Home › Facioscapulohumeral Muscular Dystrophy
Facioscapulohumeral Muscular Dystrophy clinical trials recruiting in the U.S.
8 studies for Facioscapulohumeral Muscular Dystrophy are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD
RecruitingPhase 2
Ages 18 to 60 · All sexes · Updated Sep 2, 2026 · NCT07435129Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Recruiting
Ages 18 and older · All sexes · Updated Mar 17, 2026 · NCT07478172Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)
RecruitingObservational study
Ages 5 to 17 · All sexes · Updated Feb 25, 2026 · NCT06847282Clenbuterol to Target DUX4 in FSHD
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Feb 25, 2026 · NCT06721299BetterLife FSHD: A Patient-driven Health and Research Platform
RecruitingObservational study
Ages 1 and older · All sexes · Updated Feb 20, 2026 · NCT07409142Safety and Preliminary Efficacy of ULSC in Facioscapulohumeral Muscular Dystrophy (FSHD)
RecruitingPhase 1
Ages 15 and older · All sexes · Updated Dec 8, 2025 · NCT07086521Biomarker Development for Muscular Dystrophies
RecruitingObservational studyHealthy volunteers welcome
Ages 5 and older · All sexes · Updated Nov 24, 2025 · NCT05019625Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Oct 15, 2025 · NCT00082108From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.